The last few years have been characterized by consistent growth and increasing success for Capcom, as the Japanese publisher reaps the benefits of the stellar lineup of games it has put out, and that success hit new heights in fiscal year 2022/23, which ran from April 2022 to March 2023.
In its recent quarterly fiscal report, Capcom revealed that it sold more copies of games in that period than it has ever managed in a single fiscal year, with a collective 41.7 million units sold across all platforms and all games. That’s up from 32.6 million units sold in the previous fiscal year.
Interestingly enough, the majority of these sales came from catalog titles rather than new releases, accounting for 29.3 million units (up from 24 million units in the previous fiscal year), with the likes of Monster Hunter World, Monster Hunter Rise, Resident Evil Village, Devil May Cry 5, and more.
Of course, in addition to catalog titles, Capcom saw significant sales from new releases as well, with Monster Hunter Rise: Sunbreak contributing 5.45 million units (up from 5 million units earlier this year), and the recently-released Resident Evil 4 Remake contributing 3.75 million units (which had exceeded 4 million units as of early April).
Overall, Capcom’s operating income is up 18.4% from the previous fiscal year, while consolidated net sales are up 14.4%. Overall, the company has recorded its sixth consecutive year of record high profits at all levels, and its tenth consecutive year of operating income growth. That was followed promptly afterward by its stock hitting another all-time high (and not for the first time this year), as pointed out by VGC.
Capcom is expecting similar growth in the current fiscal year as well. Catalog titles are likely to continue selling strongly, while with Street Fighter 6 and Exoprimal, the company has couple of major new releases coming up soon as well. The former is expected to sell over 10 million units in its lifetime.
Back in 2021, Capcom said that it had delayed Pragmata to 2023, but there’s no mention of the new sci-fi IP in the company’s latest financials.
